ONCO vs SRZN

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

ONCO

30.7
AI Score
VS
ONCO Wins

SRZN

29.5
AI Score

Investment Advisor Scores

ONCO

31score
Recommendation
SELL

SRZN

30score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ONCO SRZN Winner
Revenue 1.81M 10.00M SRZN
Net Income -29.25M -207.05M ONCO
Net Margin -1614.3% -2070.5% ONCO
Operating Income -27.34M -38.47M ONCO
ROE -86.3% 61.7% SRZN
ROA -47.2% -189.9% ONCO
Total Assets 61.92M 109.03M SRZN
Cash 300,000 100.35M SRZN
Current Ratio 0.06 7.56 SRZN
Free Cash Flow -9.60M -24.90M ONCO

Relative Price Performance (Last 90 Days)

ONCO 1M: +577.5% · 3M: +326.1% SRZN 1M: +35.6% · 3M: +34.3%

Current Technical Phase

ONCO

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (28.3% over 20 days), RSI 63

RSI (14): 63.3 · Price: $3.76

SRZN

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (8.0% over 20 days), RSI 61

RSI (14): 60.5 · Price: $31.88

Fundamentals Snapshot

Metric ONCO SRZN
Market Cap — —
Forward P/E 0.0 -7.0
Trailing P/E 0.0 —
Revenue (TTM) — —
Revenue Growth -0.8% 4.1%
Gross Margin 0.8% -2.6%
Operating Margin -11.9% -4.9%
EPS 3103.90 -41.94
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, ONCO is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.